TABLE 1.
Host or model | Interaction | Population or condition/intervention | Sample type or medium | Cohort or sample size | Study type | Key finding(s) | Reference |
---|---|---|---|---|---|---|---|
Humans | Bifidobacterim spp. | Newborns of GBS− and GBS+ (and IAP-treated) mothers | Stool | 52 newborns | Cross-sectional | IAP-exposed newborns have decreased gastrointestinal bifidobacteria, of which some strains were found to have antibacterial properties against GBS. | 51 |
Candida albicans | Nonpregnant | Urine and urogenital discharge | >2,400 participants | Cross-sectional | Urogenital GBS was coisolated with enterococci, Staphylococcus saprophyticus, and C. albicans. | 193 | |
Nonpregnant | Not specified | 56 participants | Retrospective | GBS was most common bacterial coisolate in a cohort of recurrent vulvovaginal candidiasis patient samples. | 194 | ||
Pregnant | Vaginal wash | 13,914 participants | Prospective | Candida colonization was accompanied by GBS in 36.8% of samples collected. | 195 | ||
Pregnant | Vaginal swab | 150 participants | Cross-sectional | Candida spp. were found in 14.9% of GBS+ women compared to 2.9% of GBS− women. | 41 | ||
Pregnant | Vaginal swab | 623 participants | Cross-sectional | Of the 7% of healthy vaginal samples in which GBS was detected, C. albicans was coisolated in 54.5% of those samples. | 42 | ||
Candida spp. | Pregnant | Vaginal swab | 7,742 participants | Cross-sectional | Risk of cervicovaginal colonization with GBS was increased with dual GBS and Candida sp. colonization. | 196 | |
Pregnant | Vaginal swab | 405 participants | Prospective | Risk of GBS colonization was increased in women cocolonized with Candida. | 43 | ||
Pregnant | Rectal and vaginal swab | 100 participants | Cross-sectional | GBS prevalence was increased in women cocolonized with Candida. | 197 | ||
Pregnant | Vaginal swab | 221 participants | Longitudinal | GBS and Candida were coisolated in 26.6% of samples. | 198 | ||
Candida spp. | Pregnant | Vaginal swab | 542 participants | Cross-sectional | GBS and Candida were coisolated in 36% of GBS+ samples. | 132 | |
Enterococcus spp. | |||||||
Staphylococcus aureus | |||||||
Candida albicans | Pregnant and nonpregnant | Vaginal swab | 430 participants | Cross-sectional | GBS had a higher risk of detection in samples with C. albicans (37.0%) and E. coli (24.6%) than in those without dual colonization. Conversely, E. coli had a higher risk of detection in GBS+ (43.3%) vs GBS− samples. | 44 | |
Escherichia coli | |||||||
Escherichia coli | Nonpregnant | Midstream and catheter urine | 202 paired samples | Cross-sectional | GBS and E. coli were cocultured from midstream urine and catheter urine collections. | 167 | |
Pregnant | Urine | 821 participants | Retrospective | GBS and E. coli were cocultured from uterine cultures taken during nonelective cesarean sections. | 163 | ||
Nonpregnant | Endocervical swab | 61 participants | Randomized trial | Of participants using a candidate HIV prophylactic, the GBS concn was inversely associated with inhibitory activity against E. coli. | 165 | ||
Escherichia coli | Nonpregnant | Rectal and vaginal swab | 1,248 participants | Prospective | Rectal GBS colonization is a predictor of GBS vaginal colonization. Other risk factors for GBS vaginal colonization include concurrent vaginal E. coli or yeast colonization. | 162 | |
Yeast | |||||||
Escherichia coli | Women diagnosed with vulvovaginitis | Vaginal swab | 4 participants | Case study | GBS was coisolated with E. coli and S. aureus. | 148 | |
Staphylococcus aureus | |||||||
Escherichia coli | Women diagnosed with tubo-ovarian abscess | Laparotomy drainage | 11 participants | Case study | GBS was coisolated with multiple aerobic and anaerobic microbes. | 164 | |
Eubacterium lentum | |||||||
Porphyromonas spp. | |||||||
Prevotella spp. | |||||||
Salmonella sp. | |||||||
Staphylococcus spp. | |||||||
Streptococcus viridans | |||||||
Atopobium vaginae | Pregnant | Vaginal swab | 248 participants | Prospective | GBS+ samples correlated with different species depending on thresholds set and analysis via cultivation or WGS. | 46 | |
Bifidobacterium spp. | |||||||
Megasphaera sp. | |||||||
Prevotella spp. | |||||||
Clostridiaceae | Infants of GBS+ mothers | Stool | 298 participants | Longitudinal | Once adjusted for demographic parameters and use of IAP, GBS+ status in mothers was associated with variation in gut microbiota composition in samples from the 6-mo visit. | 50 | |
Enterococcaceae | |||||||
Ruminococcaceae | |||||||
Bacteroidetes | Nonpregnant | Vaginal swab | 66 participants | Cross-sectional | After filtering for taxa with a logarithmic discriminant analysis score of ≥3, 10 taxa were positively associated with GBS+ status. Note that Streptococcus as a correlate has been omitted since it was not distinguished from GBS. | 33 | |
Bacteroidia | |||||||
Bacteroidales | |||||||
Clostridia | |||||||
Clostridiales | |||||||
Megasphaera | |||||||
Prevotella | |||||||
Prevotellaceae | |||||||
Veillonellaceac | |||||||
Prevotella spp. | Diabetic patient | Scrotal abscess | 1 participant | Case study | GBS and Prevotella were cocultured. | 187 | |
Pregnant | Vaginal swab | 72 participants | Prospective longitudinal | Of the women who received IAP for GBS, Prevotella relative abundance increases postpartum. | 185 | ||
Eubacterium siraeum | Nonpregnant | Vaginal lavage specimen | 432 participants | Cross-sectional | After filtering for taxa with a logarithmic discriminant analysis score of ≥2.5, 8 taxa were positively associated with GBS+ status. | 32 | |
Finegoldia magna | |||||||
Prevotella bivia | |||||||
Prevotella melaninogenica | |||||||
Peptostreptococcus anaerobiius | |||||||
Staphylococcus spp. | |||||||
Veillonella spp. | |||||||
Staphylococcus aureus | Pregnant | Vaginal swab | 4,025 participants | Cross-sectional | GBS+ status was associated with reduced coculture with Gram-positive cocci, anaerobes, and fungi, but also an increased association with specific microbes. | 40 | |
Klebsiella pneumoniae | |||||||
Staphylococcus aureus | Nonpregnant | Sterile site culture | 19,512 samples | Population-based surveillance | S. aureus was the most common coisolate (46.2%) in GBS polymicrobial sepsis cases. | 139 | |
Nonpregnant | Blood | 94 cases | Retrospective | GBS was most commonly coisolated with S. aureus or K. pneumonia. | 142 | ||
Patients diagnosed with pneumonia | Blood and respiratory samples | 1,791 cases | Retrospective | Of those identified with polymicrobial cultures, 20% were coisolated with S. aureus and 7% with P. aeruginosa | 143 | ||
Patients diagnosed with bone or joint infection | Deep surgical sample, joint aspirate, or blood | 26 cases | Retrospective | GBS was found more often in polymicrobial than monomicrobial infections. Staphylococcus spp. (S. aureus and S. ludgunesis) and E. faecalis were found in 56% and 19% of samples, respectively. | 144 | ||
Men | Skin, urinary or respiratory tract, blood, abscess, joint, bone, or unknown | 23 cases | Retrospective | Of patients with bacteremia, GBS was coisolated with B. fragilis, other beta-hemolytic Streptococcus spp., S. aureus, and Providencia stuartii. | 140 | ||
Nonpregnant adults and neonates | Blood | 18 cases | Retrospective | S. aureus was the most common coisolate in GBS bacteremia. | 141 | ||
Infants | Nasopharyngeal swab | 1,200 participants | Cross-sectional | Risk of GBS colonization increased with the detection of S. aureus. | 137 | ||
Pregnant | Rectal and vaginal swab | 2,963 samples | Prospective | S. aureus prevalence was increased in GBS+ samples. | 127 | ||
Pregnant women and neonates | Rectal and vaginal swab | 2,702 women and 2,789 infants | Retrospective | Risk of S. aureus colonization increased with the detection of GBS. | 131 | ||
Pregnant | Rectal and vaginal swab | 2,921 samples | Prospective | GBS colonization was positively associated with S. aureus. | 130 | ||
Pregnant | Vaginal swab | 6,626 participants | Cross-sectional | Risk of S. aureus colonization increased in patients with GBS. | 128 | ||
Pregnant | Rectal and vaginal swab | 5,732 participants | Prospective | Risk of S. aureus colonization increases with positive GBS colonization status. | 129 | ||
Trichomonas vaginalis | Patients with vaginitis | Vaginal swab | 327 participants | Cross-sectional | GBS was positively associated with T. vaginalis infection. | 35 | |
Cows (Holstein) | Aeromonas spp. | Dairy herds | Milk | 7 cows | Cross-sectional | GBS− subclinical mastitis milk was dominant in Firmicutes and was associated with an increase in 2 taxa. | 3 |
Chryseobacterium spp. | |||||||
Mice (KK-Ay) | Klebsiella pneumoniae | Laboratory colony | Submandibular abscess and uterine tissue | 2 mice | Case study | Of the cultures taken from submandibular abscesses, K. pneumoniae was coisolated. Of the 1 uterine culture, S. aureus was coisolated. | 119 |
Staphylococcus aureus | |||||||
Rats | Staphylococcus spp. | Pups from MWF-hDTR laboratory colony | Spleen, kidney, and heart | 4 rats | Case study | GBS was cocultured with coagulase-negative Staphylococcus spp. in limb abscesses, and E. coli was coisolated from a liver. | 120 |
Escherichia col | |||||||
Escherichia coli | Female adults from Long-Evans laboratory colony | Spleen, vaginal swab, cervical, nares, lung, brain, uterine, fetal, cardiac thrombus | 2 rats | Case study | GBS was coisolated with multiple microbes from different tissue sites or lavage specimens. | 121 | |
Enterobacter aerogenes | |||||||
Enterococcus spp. | |||||||
Staphylococcus sciuri | |||||||
Streptococcus mitis | |||||||
Streptococcus oralis | |||||||
Exptl models | Interaction | Condition/intervention | Sample type or medium | Sample size | Key finding(s) | Reference | |
In vivo | |||||||
Mice (CD-1) | Akkermansia municiphila | GBS challenge following pretreatment or cocolonization with A. muciniphila | Vaginal lavage specimen | Not specified | GBS persistence in the vaginal lumen was increased in mice dually colonized with A. muciniphila. | 175 | |
Nile tilapia | Akkermansia spp. | Oral gavage with GBS strain YM001 | Intestinal tissue | 30 fish | Administration of YM001 caused temporary and nonlethal changes in the intestinal gut microbiota, making it a safe vaccine. | 106 | |
Bacteroides spp. | |||||||
Mice | |||||||
C57BL/6J | Candida albicans | Transurethral coinfection of C. albicans and GBS | Bladder | 14–18 mice/group | C. albicans increased GBS colonization and epithelial adherence through hypha-specific adhesin Als3. | 200 | |
Vaginal coinoculation of C. albicans and GBS | Vaginal lavage specimen | 6 mice/group | The vaginal mucosal Th17 response to C. albicans is reduced in the presence of GBS. | 199 | |||
C3H/HeN and C3H/HeJ | Escherichia coli | Urinary tract coexposure to GBS and UPEC | Bladder | >10 mice/group | Immune response against UPEC is dampened by GBS sialic acid host immune signaling. | 168 | |
C57BL/6J | Gardnerella vaginalis | Vaginal coinoculation of GBS and G. vaginalis | Maternal vaginal, uterine, and placental tissues | 31 mice | Risk for vaginal colonization, ascension into the uterus, and presence in both the maternal and fetal sides of the placenta increase in the presence of G. vaginalis. | 192 | |
Rats (Wistar) | Prevotella bivia | Uterine inoculation with P. bivia and GBS | Uterine fluid | 10 rats/group | P. bivia uterine infection is increased by GBS. | 186 | |
In vitro | Candida albicans | C. albicans and GBS coculture in vitro | Spider agar and YPD | Triplicate | GBS suppresses hyphal formation through reduction of EFG1/Hwp1 expression. | 199 | |
Cocultivation of C. albicans and GBS | Yeast nitrogen base | Triplicate | GBS BspA protein promoted association of GBS with C. albicans hyphae. | 201 | |||
Cocultivation of C. albicans and GBS and cocolonization of vaginal epithelial cells | Keratinocyte serum-free medium | Triplicate | Interaction between GBS and C. albicans increases with hyphal form via C. albicans adhesin Als3 and GBS Bsp adhesins. | 202 | |||
Cocultivation of C. albicans and GBS | Blood agar | 110 C. albicans strains | C. albicans and GBS demonstrate cohemolytic (CAMP factor like) activity. | 203 | |||
Escherichia coli | Cross-feeding assays on solid media and liquid culture | M17 glucose agar | Not specified | E. coli produces ubiquinone, menaquinones, and other metabolites that may be utilized by GBS. | 166 | ||
Staphylococcus aureus | Culture of S. aureus with supernatants from bacteria associated with dysbiosis and health | BHI | Not specified | GBS supernatant increased S. aureus tst gene expression encoding toxic shock syndrome protein TSST-1. | 145 | ||
Coculture of GBS with bacterial species commonly found in female genital tract | TSB agar | Not specified | S. aureus was not inhibited by GBS isolates. | 146 |
sp., single unspecified or unknown species of a genus; spp., more than one unspecified or unknown species of a genus; IAP, intrapartum antibiotic prophylaxis; UPEC, uropathogenic E. coli; YPD, yeast extract-peptone-dextrose; BHI, brain heart infusion; TSB, tryptic (or Trypticase) soy broth.